¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"reactive functional hypoglycemia"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® hypoglycemia ÇÑ±Û ÀúÇ÷´ç(Áõ)
¼³¸í   
  Ç÷¾×¼ÓÀÇ ´ç·®ÀÌ º´ÀûÀ¸·Î °¨¼ÒµÇ¾î Àִ »óÅÂ. Á¤»óÀÎÀÇ °æ¿ì À̸¥ ¾ÆÄ§ °øº¹½Ã Ç÷´çÄ¡´Â 60~100mg/dL À̸砽ÄÈÄ¿¡µµ 160mg/dL ÀÌÇÏÀÌ´Ù. ±×·±µ¥ Ç÷´çÄ¡°¡ 50mg/dL ÀÌÇϷΠ¶³¾îÁø °æ¿ì ÀúÇ÷´çÀ̶ó°í Çϰí, À̷ΠÀÎÇØ ½Å°æÁõ¼¼°¡ ³ªÅ¸³ª´Â °ÍÀ» ÀúÇ÷´çÁõÀ̶ó ÇÑ´Ù. ½ÄÀº¶¡-°øº¹°¨-Å»·Â°¨-Çö±âÁõ µîÀÇ Áõ¼¼°¡ ³ªÅ¸³ª°í, µåµð¾î´Â Àü½Å°æ·Ã-È¥¼ö¿¡ ºüÁö¸ç, ¿À·¡ °è¼ÓµÇ¸é »ç¸ÁÇÑ´Ù. Àν¶¸°À̳ª Ç÷´ç°­ÇÏÁ¦ÀÇ °úÀ×Åõ¿©¿¡ ÀÇÇÏ¿© ÀϾ´Â °æ¿ì°¡ ¸¹°í, À̵頾àÁ¦·Î Ä¡·á Áß¿¡ Àִ ´ç´¢º´ È¯ÀÚ°¡ ½Ä»ç µîÀ» °É·¯ °øº¹ÀÏ ¶§¿¡ ÀϾ´Â ¿Ü¿¡, ÀÌÀÚÀÇ Á¾¾ç µîÀ¸·Î Àν¶¸°ÀÌ °úÀ׺кñµÉ ¶§¿¡ ÀϾ´Â °æ¿ìµµ ÀÖ´Ù. ÀúÇ÷´ç¹ßÀÛÀ» ÀÏÀ¸Å² ¶§´Â »çÅÁ¼·Ãë-Æ÷µµ´ç Á¤¸ÆÁֻ砵 ÀÇÇÏ¿© ½Å¼ÓÇϰԠȸº¹µÇ´Â ¼ö°¡ ¸¹´Ù.
  
  
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • reactive hypoglycemia
    ¹ÝÀÀÀúÇ÷´ç(Áõ)
  • alimentary hypoglycemia
    ½Ä»çÀúÇ÷´ç
  • exogenous hypoglycemia
    ¿ÜÀÎÀúÇ÷´ç
  • fasting hypoglycemia
    °øº¹ÀúÇ÷´ç
  • hypoglycemia
    ÀúÇ÷´ç(Áõ)
  • insulin-induced hypoglycemia
    Àν¶¸°À¯µµÀúÇ÷´ç(Áõ)
  • leucine sensitive hypoglycemia
    ·ù½Å¹Î°¨ÀúÇ÷´ç(Áõ)
  • postprandial hypoglycemia
    ½ÄÈÄÀúÇ÷´ç(Áõ)
  • antigen-reactive cell
    Ç׿ø¹ÝÀÀ¼¼Æ÷
  • C-reactive protein
    C-¹ÝÀÀ´Ü¹éÁú
  • reactive angioendotheliomatosis
    ¹ÝÀÀÇ÷°ü³»ÇÇÁ¾Áõ
  • reactive arthritis
    ¹ÝÀÀ°üÀý¿°
  • reactive attachment disorder
    ¹ÝÀÀ¼º¾ÖÂøÀå¾Ö
  • reactive bone excrescence
    ¹ÝÀÀ»Àµ¹Ãâ
  • reactive depression
    ¹ÝÀÀ¿ì¿ïÁõ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • functional residual capacity
    ±â´ÉÀܱâ¿ë·®
  • hypoglycemia
    ÀúÇ÷´ç(Áõ)
  • fasting hypoglycemia
    °øº¹ÀúÇ÷´ç
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • reactive hypoglycemia
    ¹ÝÀÀÀúÇ÷´çÁõ
  • alcohol-induced hypoglycemia
    ¾ËÄÚ¿ÃÀ¯µµÀúÇ÷´ç
  • alimentary hypoglycemia
    ½Ä»çÀúÇ÷´ç
  • exogenous hypoglycemia
    ¿ÜÀÎÀúÇ÷´ç
  • hypoglycemia
    ÀúÇ÷´ç(Áõ)
  • insulin-induced hypoglycemia
    Àν¶¸°À¯µµÀúÇ÷´ç(Áõ)
  • leucine sensitivity hypoglycemia
    ·ù½Å¹Î°¨ÀúÇ÷´çÁõ
  • organic hypoglycemia
    ±âÁúÀûÀúÇ÷´ç
  • postprandial hypoglycemia
    ½ÄÈÄÀúÇ÷´ç
  • spontaneous hypoglycemia
    ÀÚ¹ßÀúÇ÷´ç
  • antigen-reactive cell
    Ç׿ø¹ÝÀÀ¼¼Æ÷
  • reactive angioendotheliomatosis
    ¹ÝÀÀÇ÷°ü³»ÇÇÁ¾Áõ
  • reactive arthritis
    ¹ÝÀÀ°üÀý¿°
  • reactive perforating collagenosis
    ¹ÝÀÀ°üÅë¾Æ±³ÁúÁõ
  • reactive depression
    ¹ÝÀÀ¿ì¿ïÁõ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • reactive functional hypoglycemia
    ¹ÝÀÀ¼º ±â´É¼º ÀúÇ÷´ç(¡­Ñ¦Òöàõî¸úìÓØ).
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • reactive hypoglycemia
    ¹ÝÀÀ¼º ÀúÇ÷´çÁõ
  • Functional hypoglycemia
    ±â´É¼º ÀúÇ÷´çÁõ(¡­î¸úìÓØñø)
  • functional hypoglycemia
    ±â´ÉÀû ÀúÇ÷´ç.
  • Hypoglycemia
    ÀúÇ÷´ç·®
  • alimentary hypoglycemia
    ½Ä»ç¼º ÀúÇ÷´ç.
  • hypoglycemia
    ÀúÇ÷´ç(Áõ)(î¸úìÓØñø).
  • hypoglycemia
    ÀúÇ÷´ç(Áõ)
  • hypoglycemia, beta cell tumor
    ÀúÇ÷´ç(Áõ), º£Å¸¼¼Æ÷Á¾
  • postprandial hypoglycemia
    ½ÄÈļº ÀúÇ÷´ç(¡­î¸úìÓØ).
  • postprandial hypoglycemia
    ½ÄÈļº ÀúÇ÷´ç(ãÝý­àõ î¸úìÓØ)
  • postprandial hypoglycemia
    ½ÄÈļº(ãÝý­àõ) ÀúÇ÷´ç
  • Hyperemia reactive
    ¿ïÇ÷¹ÝÀÀ(ê¦úìÚãëë)
  • acquired reactive perforating dermatosis
    ÈÄõ¼º ¹ÝÀÀ¼º õ°ø¼º ÇǺκ´
  • acute phase reactive protein
    ±Þ¼º±â ¹ÝÀÀ¼º ´Ü¹é.
  • antigen reactive cell
    Ç׿ø¹ÝÀÀ¼¼Æ÷.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • reactive functional hypoglycemia
    ¹ÝÀÀ¼º ±â´É¼º ÀúÇ÷´ç(¡­Ñ¦Òöàõî¸úìÓØ).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • reactive hypoglycemia
    ¹ÝÀÀ¼º ÀúÇ÷´çÁõ
  • functional hypoglycemia
    ±â´ÉÀû ÀúÇ÷´ç.
  • alcohol induced hypoglycemia
    ¾ËÄڿñâÀÎ(¼º) ÀúÇ÷´ç.
  • alimentary hypoglycemia
    ½Ä»ç¼º ÀúÇ÷´ç.
  • exogenous hypoglycemia
    ¿ÜÀμº ÀúÇ÷´ç.
  • hypoglycemia
    ÀúÇ÷´ç(Áõ)
  • hypoglycemia
    ÀúÇ÷´ç(Áõ)(î¸úìÓØñø).
  • hypoglycemia, beta cell tumor
    ÀúÇ÷´ç(Áõ), º£Å¸¼¼Æ÷Á¾
  • insulin-induced hypoglycemia
    Àν¶¸°À¯µµÀúÇ÷´ç(Áõ)
  • leucine sensitivity hypoglycemia
    ·ù½Å°¨¼ö¼º ÀúÇ÷´çÁõ.
  • organic hypoglycemia
    ±âÁúÀû ÀúÇ÷´ç(ÐïòõîÜî¼úìÓØ).
  • postprandial hypoglycemia
    ½ÄÈļº ÀúÇ÷´ç(¡­î¸úìÓØ).
  • postprandial hypoglycemia
    ½ÄÈļº ÀúÇ÷´ç(ãÝý­àõ î¸úìÓØ)
  • postprandial hypoglycemia
    ½ÄÈļº(ãÝý­àõ) ÀúÇ÷´ç
  • spontaneous hypoglycemia
    Àڹ߼º ÀúÇ÷´ç(í»Û¡àõî¸úìÓØ)
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Functional deficiency
    ±â´É°áÇÌ
    [¿¾ ¿ë¾î] ±â´ÉÀû°áÇÌ
  • Functional cause
    ±â´ÉÀû¿øÀÎ
    [¿¾ ¿ë¾î] ±â´ÉÀû¿øÀÎ
  • Functional morphologic defect
    ±â´ÉÇüŰáÇÔ
    [¿¾ ¿ë¾î] ±â´ÉÀûÇüÅÂÇÐÀû°áÇÔ
  • Functional layer of endometrium
    ÀڱüӸ·±â´ÉÃþ
    [¿¾ ¿ë¾î] Àڱ󻸷±â´ÉÃþ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • functional group
    ÀÛ¿ë±â(íÂéÄÐñ)
  • functional group isomer
    ÀÛ¿ë±â(íÂéÄÐñ) À̼ºÃ¼(ì¶àõô÷)
  • C-reactive protein
    C¹ÝÀÀ(Úãëë) ´Ü¹éÁú(Ó±ÛÜòõ)
  • reactive enzyme centrifugetion
    ¹ÝÀÀÈ¿¼Ò ¿ø½ÉºÐ¸®(Úãëëý£áÈêÀãýÝÂ×î)
  • reactive hemolysis
    ¹ÝÀÀ¼º ¿ëÇ÷(ÚãëëàõéÁúì)
  • reactive lysis
    ¹ÝÀÀ¼º ¿ëÇØ(ÚãëëàõéÁú°)
  • reactive residue
    ¹ÝÀÀ¼º Àܱâ(ÚãëëàõíÑÐñ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • C-reactive protein
    C-¹ÝÀÀ¼º´Ü¹éÁú
  • functional bleeding
    ±â´ÉÀûÃâÇ÷
  • functional brain imaging
    ±â´ÉÀû³ú¿µ»ó
  • functional magnetic resonance imaging [=fMRI]
    ±â´ÉÀûÀÚ±â°ø¸í¿µ»ó
  • functional scoliosis
    ±â´É¼ºÃ´ÃßÃø¸¸Áõ
  • magnetic resonance functional neuroimaging [=MRFN]
    ÀÚ±â°ø¸í±â´ÉÀû³ú¿µ»ó
  • reactive bone excrescence
    ¹ÝÀÀ¼º°ñµ¹Ãâ
  • reactive fibrosis
    ¹ÝÀÀ¼º¼¶À¯È­
  • reactive hyperemia
    ¹ÝÀÀ¼ºÃæÇ÷
  • reactive interface
    ¹ÝÀÀ¼ºÁ¢Ã˸é
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
FA false aneurysm; Families Anonymous; Fanconi anemia; far advanced; fatty acid; febrile antigen; femor...
FAI first aid instruction; free androgen index; functional aerobic impairment; functional assessment inv...
FRC Federal Radiation Council; frozen red cells; functional reserve capacity; functional residual capaci...
HG hand grip; herpes gestationis; Heschl's gyrus; high glucose; human gonadotropin; human growth; hypog...
IHT insulin hypoglycemia test; intravenous histamine test; ipsilateral head turning
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
IIH Insulin-induced hypoglycemia
SH Severe hypoglycemia
BASFI Bath Ankylosing Spondylitis Functional Index
DFT Density Functional Theory
FACT Functional Assessment of Cancer Therapy
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • acute hypoglycemia
    ±Þ¼º ÀúÇ÷´çÁõ
  • hypoglycemia
    Ç÷´ç·® °¨¼Ò, ÀúÇ÷´çÁõ
    Ç÷¾× ÁßÀÇ Æ÷µµ´ç ³óµµ°¡ ºñÁ¤»óÀûÀ¸·Î °¨¼ÒµÈ »óÅ·Î, ÁøÀü, ½ÄÀº ¶¡, ¼Ò¸§, ü¿Â Çϰ­, µÎÅëÀÌ ÀϾ¸ç, Âø¶õ, ȯ°¢, ±â±«ÇÑ ÇൿÀ» ¼ö¹ÝÇϰí ÃÖÈÄ¿¡´Â °æ·Ã, È¥¼ö·Î µÈ´Ù.
  • late postprandial hypoglycemia
    ½ÄÈÄ Èıâ ÀúÇ÷´çÁõ
    À§ ÀýÁ¦ ÈÄ º¸°Ô µÇ´Â Èı⠴ýÇÎ Áõ»óÀÇ Çϳª.
  • acquired reactive perforating dermatosis
    ÈÄõ¼º ¹ÝÀÀ¼º õ°ø¼º ÇǺκ´
  • C-reactive protein
    C-¹ÝÀÀ ´Ü¹é, C-¹ÝÀÀ¼º ´Ü¹éÁú
  • percent reactive antibody test
    ÆÛ¼¾Æ® ¹ÝÀÀ Ç×ü °Ë»ç
  • reactive bone excrescence
    ¹ÝÀÀ¼º °ñ µ¹Ãâ
  • reactive disease
    ¹ÝÀÀ¼º Áúȯ
  • reactive hyperemia
    ¹ÝÀÀ¼º ÃæÇ÷
    Ç÷·ù¸¦ ÀϽÃÀûÀ¸·Î Á¤Áö½ÃŲ Ç÷·ù Â÷´ÜÀ» ÇØÁ¦ÇÑ ÈÄ¿¡ ºÎºÐÀûÀ¸·Î Ç÷¾×ÀÌ °úÀ×À¸·Î µÇ´Â °Í.
  • reactive lesion
    ¹ÝÀÀ¼º º´¼Ò
  • reactive schizophrenia
    ¹ÝÀÀ¼º ºÐ¿­º´
    ¾ç¼ºÀÇ ¿¹Èİ¡ ±â´ëµÇ´Â, ÁַΠȯ°æ Á¶°Ç¿¡ ±âÀÎµÈ Á¤½Å ºÐ¿­.
  • functional abnormality
    ±â´ÉÀû ÀÌ»ó
  • functional amblyopia
    ±â´É ¾à½Ã
  • functional aphasia
    ±â´É¼º ½Ç¾î
    È÷½ºÅ׸® ¶Ç´Â ÁßÁõ È÷½ºÅ׸®¼º Àå¾Ö¿¡ ±âÀÎÇÑ ½Ç¾îÁõ.
  • functional articulation
    ±â´É ±³ÇÕ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
arthritis, reactive An abacterial form of arthritis developing after infection at a site distant from the affected joint or joints. The causative bacteria cannot be cultured from synovial specimens but bacterial antigens have been demonstrated in cells from the synovial fluid and membrane. It often follows yersinia infection.
(12 Dec 1998)
brief reactive psychosis <psychiatry> A brief display of psychotic behaviour that lasts for at least several hours, but not more than one week. Typically these reactions are brought on by periods of increased stress (for example death of a loved one).
Symptoms include delusions, hallucinations, disordered thinking, impaired speech and bizarre dress.
(27 Sep 1997)
reactive arthritis Reiter's syndrome is also called reactive arthritis since it is thought to involve the immune system which is reacting to the presence of bacterial infections in the genital, urinary, or gastrointestinal systems. Accordingly, certain people's immune systems are genetically primed to react aberrantly when these areas are exposed to certain bacteria. The aberrant reaction of the immune system leads to inflammation in the joints and eyes.
(12 Dec 1998)
reactive astrocyte <cell biology> A round to oval astrocyte cell with abundant cytoplasm containing glial filaments and an eccentric nucleus; may contain two nuclei in the cell hypertrophy of astrocytes.
Synonym: gemistocyte, gemistocytic cell, reactive astrocyte, reactive cell.
(05 Mar 2000)
reactive attachment disorder Markedly disturbed and developmentally inappropriate social relatedness that begins before age 5 and is associated with grossly pathological child care. The child may persistently fail to initiate and respond to social interactions in a developmentally appropriate way (inhibited type) or there may be a pattern of diffuse attachments with nondiscriminate sociability (disinhibited type).
(12 Dec 1998)
reactive cell <cell biology> A round to oval astrocyte cell with abundant cytoplasm containing glial filaments and an eccentric nucleus; may contain two nuclei in the cell hypertrophy of astrocytes.
Synonym: gemistocyte, gemistocytic cell, reactive astrocyte, reactive cell.
(05 Mar 2000)
reactive depression A psychological state occasioned directly by an intensely sad external situation (frequently loss of a loved person), relieved by the removal of the external situation (e.g., reunion with a loved person).
(05 Mar 2000)
reactive hyperaemia Hyperaemia following the arrest and subsequent restoration of the blood supply to a part.
(05 Mar 2000)
reactive inhibition Tendency toward a lessened strength of response due to practice or activity. It is independent of the effect of reward and is a direct function of time interval since the last response and the number of preceding responses.
(12 Dec 1998)
reactive oxygen species Reactive intermediate oxygen species including both radicals and non-radicals. These substances are constantly formed in the human body and have been shown to kill bacteria and inactivate proteins, and have been implicated in a number of diseases. Scientific data exist that link the reactive oxygen species produced by inflammatory phagocytes to cancer development.
(12 Dec 1998)
reactive perforating collagenosis A rare skin disorder characterised by extrusion of collagen fibres through the epidermis; usually begins in infancy or childhood and appears clinically as recurrent umbilicated papules that resolve spontaneously. The condition may be inherited or acquired, the latter differing from Kyrle's disease because follicular involvement is absent.
(05 Mar 2000)
reactive schizophrenia Those forms of severe schizophrenic disorders which are distinguished from process schizophrenia by their more acute onset, greater relation to environmental stress, and better prognosis.
(05 Mar 2000)
child reactive disorders Reactions to an event or set of events which are considered to be of pathological degree, that have not developed into a neurosis, psychosis, or personality disorder with fixed patterns.
(12 Dec 1998)
cold-reactive antibody See: cold agglutinin.
(05 Mar 2000)
C-reactive protein <protein> This blood test is used as an indicator of acute inflammation. C-reactive protein is a protein of the pentraxin family, produced by the liver during periods of inflammation and detectable in serum in various disease conditions particularly during the acute phase of immune response. Normally C-reactive protein should be negative in the bloodstream.
C-reactive protein is synthesised by hepatocytes and its production may be triggered by prostaglandin E1 or parogen. It consists of five polypeptide sub units forming a molecule of total molecular weight 105 kD. It binds to polysaccharides present in a wide range of bacterial, fungal and other cell walls or cell surfaces and to lecithin and to phosphoryl or choline containing molecules. It is related in structure to Serum Amyloid. And C polysaccharide.
Conditions which can cause a positive C-reactive protein include: rheumatoid arthritis, lupus, pneumococcal pneumonia, rheumatic fever, cancer, tuberculosis and myocardial infarction.
A positive C-reactive protein may also be seen in the later half of pregnancy and in some who are taking birth control pills.
See: acute phase proteins
(06 Oct 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • hypoglycemia
    ÀúÇ÷´ç(Áõ)
  • reactive
    (Àڱؿ¡ ´ëÇØ)¹Î°¨ÇÑ;¹ÝÀÀÀÌ ºü¸¥;¹Ýµ¿(º¹°í)ÀûÀÎ;¹Ý¹ßÀûÀÎ;¹ÝÀÀÀûÀÎ;¹ÝÀÛ¿ëÀûÀÎ;~ly
  • functional calculus
    =PREDICATE CALCULUS
  • functional change
    ±â´É Àüȯ
  • functional illiterate
    ±â´ÉÀû ¹®¸ÍÀÚ
  • functional illiterate
    Àбâ;¾²±âÀÇ ´É·ÂºÎÁ·À¸·Î »çȸ»ýȰ¿¡ ÁöÀåÀÌÀÖ´Â »ç¶÷
  • functional representation
    Á÷´É ´ëÇ¥Á¦
  • functional shift
    ±â´É Àüȯ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á